Skip to main content
GC CELL CORPORATION logo

GC CELL CORPORATION — Investor Relations & Filings

Ticker · 144510 ISIN · KR7144510005 KO Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2025-08-01 Earnings Release
Country KR South Korea
Listing KO 144510

About GC CELL CORPORATION

http://gccell.com/en/main.do

GC CELL CORPORATION specializes in cell and gene therapy, providing a fully integrated value chain from research to commercialization. The company's core offerings include end-to-end Contract Development and Manufacturing Organization (CDMO) services for autologous and allogeneic cell therapies, comprehensive bio-logistics, and cell banking. Its integrated model supports partners throughout the entire drug life cycle, from initial development and manufacturing to clinical trials and commercial distribution. In addition to its service-based solutions, GC CELL develops proprietary cell therapy products, including Immuncell-LC, an adjuvant therapy for hepatocellular carcinoma. The company focuses on advancing treatments in areas such as immune-oncology and delivering customized solutions to enhance patient outcomes.

Recent filings

Filing Released Lang Actions
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 1% confidence The document is a formal announcement of preliminary financial results (영업(잠정)실적) for the second quarter of 2025. It provides key financial highlights such as revenue, operating profit, and net income in a tabular format. This type of disclosure is a standard initial announcement of quarterly financial performance, which fits the definition of an Earnings Release (ER). Q2 2025
2025-08-01 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company '지씨셀' covering the period from 2025-01-01 to 2025-03-31. It contains detailed financial information, business operations, management discussions, and research activities, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details share transactions (장내매수 - open market purchases) made by a company executive (Won Sung-yong, CEO of GC Cell). This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2025-05-12 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 1% confidence The document is a 'Provisional Earnings Release' (잠정실적) for GC Cell, detailing quarterly financial performance (revenue, operating profit, net income) for 2025 Q1. It follows the standard format for initial earnings announcements in the Korean market, which provides key financial highlights before the full audit is completed. As it is an initial announcement of financial results rather than a full report or a mere notification of publication, it fits the 'Earnings Release' category. Q1 2025
2025-04-30 Korean
소속부변경
Regulatory Filings Classification · 1% confidence The document is a short regulatory notice regarding a change in the company's market classification (from 'Large-cap' to 'Mid-cap' division) on the stock exchange. It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a standard regulatory announcement regarding company status, it falls under the RNS (Regulatory Filings) category.
2025-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. This type of filing is a standard regulatory requirement for directors or major shareholders to disclose their personal share transactions (insider trading). Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2025-04-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.